— Know what they know.
Not Investment Advice

LIMN Smart Money

Liminatus Pharma, Inc. Class A Common Stock
1W: -7.1% 1M: +1.6% 3M: -45.3% YTD: -87.8% 1Y: -95.5%
$3.90
+0.15 (+4.00%)
 
Weekly Expected Move ±10.0%
$3 $4 $4 $4 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 38 · $5.2M mcap · 473594 float · 104.98% daily turnover · Short 30% of daily vol

👔 Insider Trades

4 records
Date Name Title Type Shares Price Value Filing
2026-07-02 Valetudo Therapeutics LLC 10% owner J-J 3,448,926 $— $0 Filing
2026-07-02 Kim Chris officer: chief executive officer J-J 3,448,926 $— $0 Filing
2026-06-24 Valetudo Therapeutics LLC 10% owner J-J 4,373,603 $— $0 Filing
2026-06-24 Kim Chris officer: chief executive officer J-J 4,373,603 $— $0 Filing

🏛️ Congressional Trades

0 records
Date Politician Chamber Type Amount Filing
No congressional trades found

🏦 Top Institutional Holders

0 holders
Holder Shares Value Date Reported Filing
No institutional holdings found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms